NASDAQ
Capricor Therapeutics, Inc. (CAPR) has a current ratio of 9.01x as of Monday, May 25, 2026. This represents a 79.95% increase compared to its 12-month average of 5.01x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.